Join
Live feed
·
SECFilingvia Quantisnow
Revance Therapeutics Inc. logo

Revance Therapeutics Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Material Impairments, Regulation FD Disclosure, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
RVNC· Revance Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RVNC (Revance Therapeutics Inc.) and more on Quantisnow.